Immunogenicity Assessment of Pentacel (Hybrid CP20/20/5/3DT-mIPV//PRP-T) When Given at Different Times From or Concurrently With a Pneumococcal Conjugate Vaccine.
Phase of Trial: Phase III
Latest Information Update: 31 Jan 2012
At a glance
- Drugs Hib-DTaP-poliovirus vaccine; Pneumococcal 7-valent CRM197 vaccine conjugate
- Indications Diphtheria; Haemophilus infections; Pertussis; Pneumococcal infections; Poliomyelitis; Tetanus
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Sanofi
- 03 Jul 2010 Primary endpoint 'Immunological response' has been met.
- 03 Jul 2010 Results reported in Vaccine.
- 14 Nov 2008 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History